Show simple item record

dc.contributor.authorRoss, Alonzo H.
dc.contributor.authorDaou, Marie-Claire
dc.contributor.authorMcKinnon, Christine A.
dc.contributor.authorCondon, Peter J.
dc.contributor.authorLachyankar, Mahesh B.
dc.contributor.authorStephens, Robert M.
dc.contributor.authorKaplan, David R.
dc.contributor.authorWolf, David E.
dc.date2022-08-11T08:08:47.000
dc.date.accessioned2022-08-23T16:08:28Z
dc.date.available2022-08-23T16:08:28Z
dc.date.issued1996-03-01
dc.date.submitted2008-12-08
dc.identifier.citation<p>J Cell Biol. 1996 Mar;132(5):945-53.</p>
dc.identifier.issn0021-9525 (Print)
dc.identifier.doi10.1083/jcb.132.5.945
dc.identifier.pmid8603925
dc.identifier.urihttp://hdl.handle.net/20.500.14038/32454
dc.description.abstractThe high-affinity NGF receptor is thought to be a complex of two receptors , gp75 and the tyrosine kinase TrkA, but direct biochemical evidence for such an association had been lacking. In this report, we demonstrate the existence of such a gp75-TrkA complex by a copatching technique. Gp75 on the surface of intact cells is patched with an anti-gp75 antibody and fluorescent secondary antibody, the cells are then fixed to prevent further antibody-induced redistributions, and the distribution of TrkA is probed with and anti-TrkA antibody and fluorescent secondary antibody. We utilize a baculovirus-insect cell expression of wild-type and mutated NGF receptors. TrkA and gp75 copatch in both the absence and presence of NGF. The association is specific, since gp75 does not copatch with other tyrosine kinase receptors, including TrkB, platelet-derived growth factor receptor-beta, and Torso (Tor). To determine which domains of TrkA are required for copatching, we used a series of TrkA-Tor chimeric receptors and show that the extracellular domain of TrkA is sufficient for copatching with gp75. A chimeric receptor with TrkA transmembrane and intracellular domains show partial copatching with gp75. Deletion of the intracellular domain of gp75 decreases but does not eliminate copatching. A point mutation which inactivates the TrkA kinase has no effect on copatching, indicating that this enzymatic activity is not required for association with gp75. Hence, although interactions between the gp75 and TrkA extracellular domains are sufficient for complex formation, interactions involving other receptor domains also play a role.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=8603925&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttp://jcb.rupress.org/cgi/content/abstract/132/5/945
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/
dc.subjectAnimals; Cell Compartmentation; Cells, Cultured; Fluorescent Antibody Technique; Protein Binding; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, Nerve Growth Factor; Receptor, trkA; Receptors, Nerve Growth Factor; Recombinant Proteins; Spodoptera
dc.subjectLife Sciences
dc.subjectMedicine and Health Sciences
dc.titleThe neurotrophin receptor, gp75, forms a complex with the receptor tyrosine kinase TrkA
dc.typeJournal Article
dc.source.journaltitleThe Journal of cell biology
dc.source.volume132
dc.source.issue5
dc.identifier.legacyfulltexthttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=2022&amp;context=gsbs_sp&amp;unstamped=1
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/gsbs_sp/1023
dc.identifier.contextkey677741
refterms.dateFOA2022-08-23T16:08:28Z
html.description.abstract<p>The high-affinity NGF receptor is thought to be a complex of two receptors , gp75 and the tyrosine kinase TrkA, but direct biochemical evidence for such an association had been lacking. In this report, we demonstrate the existence of such a gp75-TrkA complex by a copatching technique. Gp75 on the surface of intact cells is patched with an anti-gp75 antibody and fluorescent secondary antibody, the cells are then fixed to prevent further antibody-induced redistributions, and the distribution of TrkA is probed with and anti-TrkA antibody and fluorescent secondary antibody. We utilize a baculovirus-insect cell expression of wild-type and mutated NGF receptors. TrkA and gp75 copatch in both the absence and presence of NGF. The association is specific, since gp75 does not copatch with other tyrosine kinase receptors, including TrkB, platelet-derived growth factor receptor-beta, and Torso (Tor). To determine which domains of TrkA are required for copatching, we used a series of TrkA-Tor chimeric receptors and show that the extracellular domain of TrkA is sufficient for copatching with gp75. A chimeric receptor with TrkA transmembrane and intracellular domains show partial copatching with gp75. Deletion of the intracellular domain of gp75 decreases but does not eliminate copatching. A point mutation which inactivates the TrkA kinase has no effect on copatching, indicating that this enzymatic activity is not required for association with gp75. Hence, although interactions between the gp75 and TrkA extracellular domains are sufficient for complex formation, interactions involving other receptor domains also play a role.</p>
dc.identifier.submissionpathgsbs_sp/1023
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.contributor.departmentGraduate School of Biomedical Sciences
dc.source.pages945-53


Files in this item

Thumbnail
Name:
jc1325945.pdf
Size:
3.348Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

http://creativecommons.org/licenses/by-nc-sa/4.0/
Except where otherwise noted, this item's license is described as http://creativecommons.org/licenses/by-nc-sa/4.0/